AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst

benzinga.com Cantor Fitzgerald has initiated coverage on AbbVie Inc ABBV, a global pharma company. The analyst notes that the company has positioned itself to absorb Humira biosimilar…

Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for May 2024

investorplace.com What could be better than well-established retirement stocks to buy that you can trust? How about adding to that confidence level with the backing of Wall Street analysts.…

The biggest middleman in the prescription drug supply chain now makes drugs

marketplace.org If you’ve filled a prescription in the past decade, you’re probably familiar with at least one pharmacy benefit manager. The “big three” PBMs are Express Scripts, CVS…

3 Magnificent Stocks That Are Passive Income Machines

finance.yahoo.com There are many dividend stocks on the market. Some will eventually cut or suspend their payouts due to company-specific, economic, or broader market issues. Those aren't the…

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

finance.yahoo.com The healthcare industry is a fantastic place to find passive income. Healthcare is recession-proof, and there's always a need for better technology and new treatments. The…

3 Rock-Solid Dividend Stocks That Are Ideal for Retirees

finance.yahoo.com Dividend stocks can be great assets for you in retirement. They can provide you with some recurring income, and they can be relatively safe places to invest your money into…

Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates

finance.yahoo.com Teva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's blockbuster arthritis drug Humira in the coming weeks after it posted mixed…

Buy These 2 Picks If Nothing Else In May

seekingalpha.com How's your New Year's resolution going? Have you been able to maintain it all the way until May? Or did it crash and burn in the first few weeks of the year? It's not…

Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare

investorplace.com For your wellness and your portfolio Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile…

AbbVie Tracking for New Highs in 2024

marketbeat.com Shares of AbbVie NYSE: ABBV fell hard in the wake of its Q1 earnings report, but the dip is over. The market response to slowing Humira sales is overshadowed by strength in…